N4 Pharma Share Price (N4P)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
N4 Pharma Plc	LSE:N4P	London	Ordinary Share	GB00BYW8QM32	ORD 0.4P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	0.00	0.0%	1.85	0.00	08:00:20

Bid Price		Offer Price	High Price	Low Price	Open Price
1.80		1.90	1.85	1.85	1.85

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology		-1.84	-0.85		3

Last Trade Time	Trade Type	Trade Size	Trade Price	Currency
-	O	0	1.85	GBX

Related Shares
Astrazeneca (AZN), Gsk (GSK), Midatech Pharma (MTPH), Bermele (BERM)

N4 Pharma (N4P) Latest News

N4 Pharma News

Date	Time	Source	Headline
17/1/2023	16:23	ALNC	TRADING UPDATES: hVIVO wins contract; Dev Clever cancels shares
17/1/2023	14:05	UKREG	N4 Pharma PLC Second Price Monitoring Extn
17/1/2023	14:00	UKREG	N4 Pharma PLC Price Monitoring Extension
17/1/2023	11:05	UKREG	N4 Pharma PLC Second Price Monitoring Extn
17/1/2023	11:00	UKREG	N4 Pharma PLC Price Monitoring Extension
17/1/2023	09:05	UKREG	N4 Pharma PLC Second Price Monitoring Extn
17/1/2023	09:00	UKREG	N4 Pharma PLC Price Monitoring Extension
17/1/2023	07:00	UKREG	N4 Pharma PLC Oral application update
30/11/2022	17:28	UKREG	N4 Pharma PLC Holding(s) in Company
30/11/2022	07:00	UKREG	N4 Pharma PLC Total Voting Rights

More N4 Pharma News

N4 Pharma Investors N4 Pharma Takeover Rumours

N4 Pharma (N4P) Share Charts 1 Year N4 Pharma Chart
1 Month N4 Pharma Chart	Intraday N4 Pharma Chart

N4 Pharma (N4P) Discussions and Chat

N4 Pharma Forums and Chat

Date	Time	Title	Posts
15/1/2023	11:33	N4 Pharma	3,897
20/5/2021	07:25	N4 Pharma - Making good drugs better.	4,391
14/9/2020	06:40	N4P Covid-19 Wealth Warning	108

Add a New Thread

N4 Pharma (N4P) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
2023-02-06 12:27:31	1.83	25,000	456.25	O
2023-02-06 09:57:13	1.83	28,000	511.00	O
2023-02-06 09:47:33	1.91	524	9.99	O

View all N4 Pharma trades in real-time

N4 Pharma (N4P) Top Chat Posts

Top Posts
Posted at 18/11/2022 09:53 by goforgold1 Fuvking hell Turner Pope . The cowboys of AIM . This share is doomed it's either TP or Death Spiral Loan . Wow Another con full of them at moment . Never buy a share from were TP involved your lose everything Read Full Thread Follow Reply
Posted at 18/11/2022 09:48 by nobbygnome Wow, bid below the placing price! Read Full Thread Follow Reply
Posted at 18/11/2022 07:15 by nobbygnome Ouch. Further massive dilution at a very low price! Read Full Thread Follow Reply
Posted at 01/11/2022 12:45 by ch1rp I think N4P know a little bit more than you Nobbs. After all you have been shorting here for years. Read Full Thread Follow Reply
Posted at 04/10/2022 06:16 by jakleeds Looks very promising 4 October 2022 N4 Pharma Plc ("N4 Pharma" or the "Company") Double siRNA Testing Update N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec(R) , a novel delivery system for cancer treatments and vaccines, is pleased to announce successful in vitro testing of Nuvec(R) loaded with two small interfering RNA (siRNA) probes. On 14 September 2022, the Company announced a strategic update highlighting its intention to focus its further development work on multiple loaded siRNA on Nuvec(R) . T he Company has now completed initial in vitro testing of Nuvec(R) loaded with two generic siRNA probes, GFP (Green Fluorescent protein) and EHMT-2 (Euchromatic Histone Lysine Methyltransferase 2 ) at the same time. The siRNA probes were loaded onto Nuvec(R) in equal amounts, at a concentration previously shown to be active. Testing demonstrated that both siRNA probes when loaded onto Nuvec(R) were able to significantly silence their respective targets. Nigel Theobald, Chief Executive Officer of the Company, commented : "Showing that Nuvec(R) loaded with two generic siRNA probes still achieves significant silencing of their respective genes is validation for us to now begin the further work that we announced on 14 September with EGFR and BCl-2 in a PC9 lung cancer model. "Achieving the initial successful testing of Nuvec (R) with the generic GFP and EHMT-2 siRNA will also allow us to commence commercial outreach discussions which will only be further strengthened by the results from the new work we are undertaking ." Read Full Thread Follow Reply
Posted at 14/6/2022 12:10 by ch1rp ? If you think that then get out the share. Read Full Thread Follow Reply
Posted at 14/2/2022 10:48 by pwal N4P has got all these patents but when are we going to see sales?? Read Full Thread Follow Reply
Posted at 14/12/2021 13:41 by andymunchkin Master RSI28 Aug '20 - 11:57 - 2797 of 3785 0 1 0 Able to buy at middle price 11.675p ( 11.50 v 11.75p ) Only WINS at offer 2 at bid Master RSI28 Aug '20 - 12:05 - 2798 of 3785 0 3 0 that's it no more cheap shares, WINS has gone to 12p again 12p 30,000 WINS 13:00 ———;—— Hi MusterBater whats WINS @ now cheers. Btw uSoundLike RampngBufoon whysTht???? Read Full Thread Follow Reply
Posted at 13/12/2021 11:15 by earwacks The rns is obviously unexpected as Nigel admitted the results were 'unexpected.' The point is the trials continue on the vaccine at no cost to N4P. Unfortunately that means no revenue continuing for the time being. However I don't see this as a change in strategy, rather a continuation. The results from Gene therapy have been very encouraging showing not just a suppression in tumours but also a reduction. So why would they not progress this further. Market reaction is understandable. In the longer term I see more positives than negatives. Fortunately this is not a one trick pony Read Full Thread Follow Reply
Posted at 27/7/2021 22:08 by tankerton The share price Angel analyst report suggested that N4`s share price should be 10 times higher than its current price to align it to its peers. Even at 10 times its current valuation, there would still be a strong argument for a takeover but at its current valuation, it would be a sitting duck to an opportunistic bid. Thankfully I don`t expect N4 to remain at this valuation for much longer as we have a number of big news items coming up. Read Full Thread Follow Reply

N4 Pharma share price data is direct from the London Stock Exchange

Your Recent History

LSE

N4P

N4 Pharma

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Advertise Here

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US

P: V: D:20230207 08:46:44